Ovarian Cancer


Relevance: Medium
Most relevant for: People with Lynch syndrome
Study: Early trial of new vaccine shows promise for people with Lynch syndrome
The Nous-209 vaccine for preventing cancer in people with Lynch syndrome was tested in an early-phase study. The safety and immune response results were encouraging. An immune response was seen in most participants, suggesting that the vaccine may help reduce the chance of developing cancer in people with Lynch syndrome. (posted 3/23/2026)
READ MORE ›

Relevance: High
Most relevant for: People who are experiencing pelvic side effects related to treatment or surgery
Article: Pelvic health therapy improves quality of life after treatment or prevention
Pelvic health therapy can significantly improve comfort, function and quality of life for people experiencing pelvic pain, bladder or bowel issues, and sexual dysfunction after cancer treatment or preventive surgery. This article highlights the importance of restoring tissue mobility, strengthening the pelvic floor and providing emotional support to empower survivors and previvors. (posted 3/23/2026)
READ MORE ›

Relevance: Medium-High
Most relevant for: People with advanced ovarian, fallopian tube or primary peritoneal cancer
Update: Promising FDA updates in ovarian cancer
This update highlights recent FDA news focused on ovarian cancer, including a new treatment option and two promising investigational drugs that received the FDA’s Breakthrough Therapy designation. These updates may provide more treatment choices for people with ovarian cancer. (posted 3/09/26)
READ MORE ›

Relevance: Medium-High
Most relevant for: People who have had or are considering liquid biopsy testing
Topic: What Patients Need to Know About Liquid Biopsies in Cancer Care
Liquid biopsies are tests that look for signs of cancer in blood or other body fluids. These signs can include cancer cells that have broken away from a tumor, pieces of cancer cell DNA and proteins or other biomarkers found in cancer cells. Liquid biopsies can be used to screen for cancer before a cancer diagnosis or guide treatment after a diagnosis. (posted 2/6/26)
READ MORE ›

Relevance: High
Most relevant for: Men and women diagnosed with breast cancer who have a BRCA1 or BRCA2 mutation
Study: Understanding the risks of a second cancer after a breast cancer diagnosis in people with BRCA1 and BRCA2 mutations
After breast cancer, people who have a BRCA1 or BRCA2 mutation face a greater risk of a second cancer compared to individuals without a BRCA mutation. This study helps to better understand this risk so that breast cancer survivors with mutations can receive informed, personalized plans for surveillance and follow-up care. (Posted 12/11/25)
READ MORE ›

Relevance: Medium-High
Most relevant for: People with an inherited mutation that increases cancer risk who are interested in sexual health
Study: Impact on sexual well-being among people with an inherited BRCA mutation
This study looked at sexual well-being in those with an inherited BRCA1 or BRCA2 mutation. Knowledge about having an inherited BRCA1 or BRCA1 mutation did not influence sexual health. However, menopause and cancer diagnosis was had a significant impact on sexual health and sexual function. (Posted 2/13/25)
Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: People with a BRCA1 or BRCA2 mutation who have had risk-reducing surgery to remove their ovaries
Study: Risk of peritoneal cancer is low for people with an inherited BRCA mutation after surgery
The risk of peritoneal cancer is low in people with an inherited BRCA1 or BRCA2 mutation after risk-reducing ovary removal (oophorectomy). The risk was even lower when risk-reducing surgery was done at a young age and after 2005 when removal of the fallopian tubes was included in the procedure. The findings of this research support the theory that like ovarian cancer, peritoneal cancer begins in the fallopian tubes and reinforces the age recommendation for surgery. (Posted 1/23/25)
Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: People at high risk for hereditary cancer
Guideline: Hereditary cancer gene guidelines expand
The National Comprehensive Cancer Network regularly updates guidelines for several types of hereditary cancer. These recommendations often change when new research is published. Recently, the NCCN expanded its guidelines to include information on hereditary prostate and gastric cancers. (Posted 1/6/25)
Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: People with cancer interested in using cannabis to help manage symptoms.
Study: Use of cannabis for cancer symptom management
Among people with cancer, interest in the use of cannabis to manage cancer symptoms and treatment side effects is high. The world's leading professional organization of oncologists has published strategies to help adults with cancer and their healthcare providers have open, nonjudgmental discussions about the use of cannabis to manage cancer symptoms. (Posted 9/27/24)
Este artículo está disponible en español.
READ MORE ›

Relevance: High
Most relevant for: People diagnosed with cancer
Topic: Acupressure for cancer symptom relief
Acupressure is a safe treatment that can be used to relieve some symptoms of cancer and side effects of treatment. Light pressure applied to key points on the body may help with fatigue, sleep, nausea and possibly other symptoms as well. (Posted 8/1/24)
Este artículo está disponible en español.
READ MORE ›